Tilray Brands (TLRY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for November 21, 2024, to be held virtually, with full participation rights for shareholders.
Key proposals include director elections, auditor ratification, increase in authorized shares, and governance amendments.
Board recommends voting in favor of all proposals, emphasizing long-term value creation and shareholder engagement.
Voting matters and shareholder proposals
Shareholders will vote on electing two Class III directors, ratifying PricewaterhouseCoopers LLP as auditor, increasing authorized shares, and governance changes to declassify the board and allow director removal without cause.
Board recommends voting FOR all proposals.
Shareholders may submit proposals and director nominations for the 2025 meeting by specified deadlines.
Board of directors and corporate governance
Board consists of seven members, with a mix of independent and non-independent directors.
Governance proposal seeks to declassify the board and allow annual director elections and removal without cause.
Board diversity matrix disclosed; majority of directors are independent.
Board leadership combines CEO and Chair roles, with a separate independent Vice Chair.
Board committees (Audit, Compensation, Nominating & Governance) are fully independent and meet regularly.
Latest events from Tilray Brands
- Acquisition creates a $500M global craft beverage platform and accelerates international growth.TLRY
M&A announcement2 Mar 2026 - Balanced growth across cannabis, beverages, and distribution, with innovation and efficiency focus.TLRY
TD Cowen 9th Annual Future of the Consumer Conference3 Feb 2026 - Record revenue and EBITDA growth, margin gains, and strong outlook for continued expansion.TLRY
Q4 20242 Feb 2026 - Q1 revenue hit $200M (+13% YoY), led by beverage growth and margin gains, with net loss improvement.TLRY
Q1 202519 Jan 2026 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies advancing.TLRY
Q2 202510 Jan 2026 - Record Q2 revenue, improved net loss, and net cash position; 2026 guidance reaffirmed.TLRY
Q2 20269 Jan 2026 - Diversified global platform drives growth in cannabis, beverage, and wellness with strong financials.TLRY
Investor Presentation8 Jan 2026 - Record Q1 revenue and return to profitability driven by cannabis and distribution growth.TLRY
Q1 202622 Dec 2025 - Proxy covers director election, auditor ratification, pay, and board declassification proposals.TLRY
Proxy Filing2 Dec 2025